Dae Jung Kim
Ajou University
H-index: 60
Asia-South Korea
Top articles of Dae Jung Kim
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations | Journal of Diabetes Investigation | Kyoung Hwa Ha Dae Jung Kim | 2024/3 |
Lower risk of cardiovascular events and death associated with initiation of sodium‐glucose cotransporter‐2 inhibitors versus sulphonylureas: Analysis from the CVD‐REAL 2 study | Diabetes, Obesity & Metabolism | SY Goh MN Kosiborod CSP Lam MA Cavender S Kohsaka | 2023/4/13 |
Empagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in routine care in East Asia: Results from the EMPRISE study | Journal of Diabetes Investigation | Dae Jung Kim Wayne H‐H Sheu Wook‐Jin Chung Daisuke Yabe Kyoung Hwa Ha | 2023/3 |
2023 clinical practice guidelines for diabetes mellitus of the Korean diabetes association | Jong Han Choi Kyung Ae Lee Joon Ho Moon Suk Chon Dae Jung Kim | 2023/9 | |
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the … | Diabetes & metabolism | Avraham Karasik Stefanie Lanzinger Elise Chia-Hui Tan Daisuke Yabe Dae Jung Kim | 2023/3/1 |
Associations of updated cardiovascular health metrics, including sleep health, with incident diabetes and cardiovascular events in older adults with prediabetes: A nationwide … | Diabetes Research and Clinical Practice | Kyoung Hwa Ha Dae Jung Kim Seung Jin Han | 2023/9/1 |
Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes | The Korean Journal of Internal Medicine | Kyoung Hwa Ha Kyung Ae Lee Kyung-Do Han Min Kyong Moon Dae Jung Kim | 2023/1 |
Long-term Effectiveness of the National Diabetes Quality Assessment Program in South Korea | Diabetes Care | Ji Hye Huh Serim Kwon Gui Ok Kim Bo Yeon Kim Kyoung Hwa Ha | 2023/9/1 |
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin … | Cardiovascular diabetology | Dorte Vistisen Bendix Carstensen Patorno Elisabetta Stefanie Lanzinger Elise Chia-Hui Tan | 2023/8/31 |
Short-term air pollution exposure and risk of acute exacerbation of chronic obstructive pulmonary disease in korea: a national time-stratified case-crossover study | International journal of environmental research and public health | Yun Jung Jung Eun Jin Kim Jung Yeon Heo Young Hwa Choi Dae Jung Kim | 2022/2/28 |
Maintaining physical activity is associated with reduced major adverse cardiovascular events in people newly diagnosed with diabetes | Journal of Obesity & Metabolic Syndrome | Duhoe Kim Jaehun Seo Kyoung Hwa Ha Dae Jung Kim | 2022/6/6 |
Healthcare resource utilization in patients treated with empagliflozin in East Asia | Journal of Diabetes Investigation | Wayne H‐H Sheu Yutaka Seino Elise Chia‐Hui Tan Daisuke Yabe Kyoung Hwa Ha | 2022/5 |
Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study | The Lancet Diabetes & Endocrinology | Dunya Tomic Jedidiah I Morton Lei Chen Agus Salim Edward W Gregg | 2022/11/1 |
Trends in all-cause mortality among people with diagnosed diabetes: a multi-country analysis of aggregate data from 21 million deaths in diabetes in high-income settings | The Lancet Diabetes & Endocrinology | Dianna J Magliano Lei Chen Bendix Carstensen Edward W Gregg Meda E Pavkov | 2022/2/1 |
Empagliflozin reduces the progression of hepatic fibrosis in a mouse model and inhibits the activation of hepatic stellate cells via the Hippo signalling pathway | Biomedicines | Yu-Jung Heo Nami Lee Sung-E Choi Ja-Young Jeon Seung-Jin Han | 2022/4/29 |
1143-P: Lifetime Risk, Life Expectancy, and Years of Life Lost to Type 2 Diabetes in a Global Modelling Study of Six Countries | Diabetes | Dunya Tomic Lei Chen Jedidiah I Morton Edward W Gregg Meda E Pavkov | 2022/6/1 |
The degree of glycemic control for the first three months determines the next seven years | Journal of Korean Medical Science | Nami Lee Dae Jung Kim | 2022/10/10 |
Renin-angiotensin-aldosterone system inhibitors and risk of Cancer: a Population-Based Cohort Study using a Common Data Model | Hypertension | Andrea Conversano Francesco Melillo Antonio Napolano Evgeny Fominskiy Marzia Spessot | 2020/8 |
Association between metabolically healthy obesity and subclinical atherosclerosis in the cardiovascular and metabolic diseases Etiology Research Center (CMERC) cohort | Ahmed Malki Riyaz Ahamed Shaik Waqas Sami | 2023/10/3 | |
Recommendation on an updated standardization of serum magnesium reference ranges | European Journal of Nutrition | Andrea Rosanoff Christina West Ronald J Elin Oliver Micke Shadi Baniasadi | 2022/10 |
